Replies to post #345837 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

The 10Q will not show any surprises for the market zero.
The 10Q will however indicate NWBO still being active and functioning which will incite a relief rally mark my words

[branster]

heads, its all relative with good TLD which I think has a 90 plus chance of success, this existing SP will be a thing of the past along with the late 10Q's etc.

[exwannabe]

Heads, that has been pointed out before.

But the people who bother to factor in financials when evaluating companies like this know that despite the very large (maybe $300M ) non-cash loss, it has zero effect on the company going forward. It is effectively a marker for the warrant/option dilution, which is already factored in when we say 1.4B fully diluted.

The significant financial numbers would be increased spending on Sawston and Flaskworks. Those are totally unknown, and would affect how long they go to the next financing. Even then, numbers matter little IF they can produce TLD.